Q4 FY2025 · Presentation
Investor Call on Phase 3 PV Data Presented at ASCO 2025 · 49 pages
Read Takeda Pharmaceutical Co. Ltd.'s results firsthand
Preview the first 2 pages of this presentation
Create a free account to start reading
Full documents are included with Professional